Announcements Trials
Browse Landscape

Phase

Phase NA 41Phase 2 4Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 7Active not recruiting 4Completed 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Practice Guidelines as Topic × Clear all
NCT03125070 2025-01-29

INSPIRE

Fred Hutchinson Cancer Center

Phase 3 Completed
546 enrolled 13 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT03103321 2025-01-27

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
158 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡